NYSE | HotStoqx.com

NYSE Stocks

Simcere Pharmaceutical Ads, (NYSE:SCR)

A leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases with high incidence.

Kingsway Financial Services, (NYSE:KFS)

Get Quote

Kingsway Financial Services Inc. focuses on non-standard automobile insurance in North America. Kingsway's primary businesses are the insuring of automobile risks for drivers who do not meet the criteria for coverage by standard automobile insurers, and commercial automobile insurance.

Theragenics Corp., (NYSE:TGX)

Get Quote

Theragenics Corporation® is a medical device company serving the surgical products and prostate cancer treatment markets. Its surgical products business manufactures and distributes wound closure, vascular access, and specialty needle products.

General Steel Holdings INC., (NYSE:GSI)

Get Quote

This company specializes in metal production and fabrication.

Harbinger Group Inc., (NYSE:HRG)

Get Quote

Harbinger Group Inc., formerly known as Zapata Corporation, is a holding company which has approximately $151.9 million in cash.

Paragon Shipping Inc., (NYSE:PRGN)

Get Quote

BlerbParagon Shipping Inc. is an international shipping company specializing in the transportation of drybulk cargoes. Our vessels are able to trade worldwide in a multitude of trade routes carrying a wide range of cargoes covering a number of industries.

Rite Aid Pharmacy, (NYSE:RAD)

Get Quote

Rite Aid Corporation is one of the nation's leading drugstore chains, operating nearly 4,800 stores in 31 states and the District of Columbia.

THE MARKETS

In today's markets maximizing returns or outperforming the market isn't just about reaping profits. Investing is the active redirection of resources and assets to create benefits for the future.

INVICTUS MD ANNOUNCES BINDING LETTER OF INTENT TO ACQUIRE 20% WASHINGTON I502 CULTIVATION & PROCESSING LICENSE

Invictus MD Strategies Corp. has entered into a binding letter of intent to acquire a Tier 2 State of Washington cultivation and processing licence.

Invictus MD will pay $1-million (U.S.) cash by way of a convertible debenture to Cannera Equipment Leasing. CEL has committed up to $1-million (U.S.) by way of equipment financing and tenant upgrades to the licensed facility, which is currently in final stages of construction and will have the capacity to produce 2,500 kilograms annually.

Upon final licensing approval by the Washington State Liquor and Cannabis Board, Invictus MD will pay $2-million (U.S.) and issue 800,000 shares with a maximum value of $2-million (U.S.) to CEL to secure its option to execute, assign or transfer 20-per-cent equity . The operation has a strategic partnership with a renowned genetics and extracts brand located in California, with an established foothold in the California, Nevada and Washington market.

The details of the binding letter of intent will also grant Invictus MD the right of first refusal on all future capital raises, any shares offered for sale and listing on any publicly traded exchange.

Dan Kriznic, chief executive officer, commented: "This is yet another strategic acquisition for Invictus MD. The operations team has an established foothold within the California, Washington and Nevada markets. With this placeholder acquisition, Invictus MD will be well positioned to establish and execute operations in Washington and continue to build Future Harvest's brand through its i502 partners."

About Invictus MD Strategies

Invictus MD targets cannabis companies with proven brands, strong customer focus and significant growth potential.

For Further Information On This Under Valued Company Please Visit www.invictus-md.com